v3.25.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Operating activities:    
Net income (loss) $ 95,590 $ (371,555)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:    
Depreciation and amortization expense 68,418 50,224
Share-based compensation expenses 246,287 219,304
Acquired in-process research and development 500 0
Gain on deconsolidation of a subsidiary 0 (3,735)
Amortization of research and development cost share liability (45,569) (35,039)
Other items, net 15,128 5,413
Changes in operating assets and liabilities:    
Accounts receivable (73,369) (173,896)
Inventories 6,174 (35,949)
Other assets (45,316) (32,233)
Accounts payable (35,852) 2,192
Accrued expenses and other payables 75,625 (28,256)
Other liabilities 64 (630)
Net cash provided by (used in) operating activities 307,680 (404,160)
Investing activities:    
Purchases of property, plant and equipment (100,233) (266,528)
Purchase of intangible asset (20,000) (4,674)
Proceeds from sale or maturity of investments 1,800 2,655
Purchase of in-process research and development (60,000) (31,800)
Other investing activities (10,113) (20,516)
Net cash used in investing activities (188,546) (320,863)
Financing activities:    
Proceeds from long-term loan 0 9,053
Repayment of long-term loan (16,799) (14,020)
Proceeds from short-term loans 221,521 324,412
Repayment of short-term loans (275,782) (157,490)
Payments of withholding taxes from share-based awards (24,195) 0
Proceeds from option exercises and employee share purchase plan 96,503 20,355
Other financing activities 0 3,000
Net cash provided by financing activities 1,248 185,310
Effect of foreign exchange rate changes, net 26,957 (28,340)
Net increase (decrease) in cash, cash equivalents, and restricted cash 147,339 (568,053)
Cash, cash equivalents, and restricted cash at beginning of period 2,638,747 3,185,984
Cash, cash equivalents, and restricted cash at end of period 2,786,086 2,617,931
Supplemental cash flow information:    
Cash and cash equivalents 2,756,056 2,592,655
Short-term restricted cash 15,802 23,155
Long-term restricted cash 14,228 2,121
Income taxes paid 77,033 45,636
Interest expense paid 24,018 24,148
Supplemental non-cash information:    
Capital expenditures included in accounts payable and accrued expenses 57,923 115,564
ROU assets obtained in exchange for new operating lease liabilities 18,141 27,267
Increase in equity investment from deconsolidation of a subsidiary $ 0 $ 40,798